About Technology Issues FAQ

Links

Change in Drusen Volume as a Novel Clinical Trial Endpoint for the Study of Complement Inhibition in Age-related Macular Degeneration

Change in Drusen Volume as a Novel Clinical Trial Endpoint for the Study of Complement Inhibition in Age-related Macular Degeneration — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.